229 related articles for article (PubMed ID: 20006567)
21. In vitro inhibition of heme oxygenase isoenzymes by metalloporphyrins.
Wong RJ; Vreman HJ; Schulz S; Kalish FS; Pierce NW; Stevenson DK
J Perinatol; 2011 Apr; 31 Suppl 1():S35-41. PubMed ID: 21448202
[TBL] [Abstract][Full Text] [Related]
22. Prevention of neonatal hyperbilirubinemia by tin protoporphyrin IX, a potent competitive inhibitor of heme oxidation.
Drummond GS; Kappas A
Proc Natl Acad Sci U S A; 1981 Oct; 78(10):6466-70. PubMed ID: 6947237
[TBL] [Abstract][Full Text] [Related]
23. Tin-mesoporphyrin in the treatment of refractory hyperbilirubinemia due to Rh incompatibility.
Maisels MJ; Yang H
J Perinatol; 2012 Nov; 32(11):899-900. PubMed ID: 23128060
[TBL] [Abstract][Full Text] [Related]
24. Metalloporphyrins for the treatment of neonatal jaundice.
Dennery PA
Curr Opin Pediatr; 2005 Apr; 17(2):167-9. PubMed ID: 15800405
[TBL] [Abstract][Full Text] [Related]
25. Neonatal hyperbilirubinemia and the role of unbound bilirubin.
Hegyi T; Kleinfeld A
J Matern Fetal Neonatal Med; 2022 Dec; 35(25):9201-9207. PubMed ID: 34957902
[TBL] [Abstract][Full Text] [Related]
26. Treatment of hyperbilirubinemia pharmacologic approach SnMP(tin-mesoporphyrin).
Martínez JC; García HO; Otheguy LE; Drummond GS; Kappas A
J Perinatol; 2001 Dec; 21 Suppl 1():S101-3; discussion S104-7. PubMed ID: 11803428
[No Abstract] [Full Text] [Related]
27. Sn-mesoporphyrin suppression of hyperbilirubinemia in EHBR/Eis rats, an animal model of Dubin-Johnson syndrome.
Drummond GS; Kappas A
Pharmacology; 1998 Mar; 56(3):158-64. PubMed ID: 9532616
[TBL] [Abstract][Full Text] [Related]
28. The use of metalloporphyrins for the chemoprevention of neonatal jaundice.
Stevenson DK; Rodgers PA; Vreman HJ
Am J Dis Child; 1989 Mar; 143(3):353-6. PubMed ID: 2644817
[TBL] [Abstract][Full Text] [Related]
29. Pharmacological therapies for unconjugated hyperbilirubinemia.
Cuperus FJ; Hafkamp AM; Hulzebos CV; Verkade HJ
Curr Pharm Des; 2009; 15(25):2927-38. PubMed ID: 19754369
[TBL] [Abstract][Full Text] [Related]
30. Carbon monoxide excretion as an index of bilirubin production in rhesus monkeys.
Vreman HJ; Rodgers PA; Gale R; Stevenson DK
J Med Primatol; 1989; 18(6):449-60. PubMed ID: 2614809
[TBL] [Abstract][Full Text] [Related]
31. New approach to prevention of kernicterus.
Cooke RW
Lancet; 1999 May; 353(9167):1814-5. PubMed ID: 10359401
[No Abstract] [Full Text] [Related]
32. Suppression of bilirubin production in the Crigler-Najjar type I syndrome: studies with the heme oxygenase inhibitor tin-mesoporphyrin.
Galbraith RA; Drummond GS; Kappas A
Pediatrics; 1992 Feb; 89(2):175-82. PubMed ID: 1734381
[TBL] [Abstract][Full Text] [Related]
33. The effect of clofibrate on hyperbilirubinemia of term neonates.
Habibi M; Mahyar A; Ayazi P; Ahmadabadi F; Javadi A
Acta Med Iran; 2012; 50(1):21-5. PubMed ID: 22267374
[TBL] [Abstract][Full Text] [Related]
34. Sn-protoporphyrin inhibition of fetal and neonatal brain heme oxygenase. Transplacental passage of the metalloporphyrin and prenatal suppression of hyperbilirubinemia in the newborn animal.
Drummond GS; Kappas A
J Clin Invest; 1986 Mar; 77(3):971-6. PubMed ID: 3753986
[TBL] [Abstract][Full Text] [Related]
35. Neonatal hyperbilirubinemia in Japanese neonates: analysis of the heme oxygenase-1 gene and fetal hemoglobin composition in cord blood.
Kanai M; Akaba K; Sasaki A; Sato M; Harano T; Shibahara S; Kurachi H; Yoshida T; Hayasaka K
Pediatr Res; 2003 Aug; 54(2):165-71. PubMed ID: 12736395
[TBL] [Abstract][Full Text] [Related]
36. Suppression of hyperbilirubinemia in the rat neonate by chromium-protoporphyrin. Interactions of metalloporphyrins with microsomal heme oxygenase of human spleen.
Drummond GS; Kappas A
J Exp Med; 1982 Dec; 156(6):1878-83. PubMed ID: 6897419
[TBL] [Abstract][Full Text] [Related]
37. Strategies for neonatal hyperbilirubinemia: a literature review.
Wells C; Ahmed A; Musser A
MCN Am J Matern Child Nurs; 2013; 38(6):377-82;quiz 383-4. PubMed ID: 24145492
[TBL] [Abstract][Full Text] [Related]
38. Outcomes among newborns with total serum bilirubin levels of 25 mg per deciliter or more.
Newman TB; Liljestrand P; Jeremy RJ; Ferriero DM; Wu YW; Hudes ES; Escobar GJ;
N Engl J Med; 2006 May; 354(18):1889-900. PubMed ID: 16672700
[TBL] [Abstract][Full Text] [Related]
39. Characterization of porphyrin heme oxygenase inhibitors.
Vreman HJ; Cipkala DA; Stevenson DK
Can J Physiol Pharmacol; 1996 Mar; 74(3):278-85. PubMed ID: 8773407
[TBL] [Abstract][Full Text] [Related]
40. Sn-protoporphyrin use in the management of hyperbilirubinemia in term newborns with direct Coombs-positive ABO incompatibility.
Kappas A; Drummond GS; Manola T; Petmezaki S; Valaes T
Pediatrics; 1988 Apr; 81(4):485-97. PubMed ID: 3281127
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
